title: Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation.
authors.affiliation: Department of Surgery, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Desai
authors.forename: J D
authors.initials: JD
authors.lastname: Scandling
authors.forename: C
authors.initials: C
authors.lastname: Knoppel
authors.forename: D C
authors.initials: DC
authors.lastname: Dafoe
authors.forename: E J
authors.initials: EJ
authors.lastname: Alfrey
mesh_terms: D000328:Adult; D002140:California; D003365:Costs and Cost Analysis; D005260:Female; D006084:Graft Rejection / Q000191:economics / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000191:economics / Q000627:therapeutic use*; D016035:Pancreas Transplantation / Q000276:immunology*; D011183:Postoperative Complications; D012074:Remission Induction; D012189:Retrospective Studies
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3